| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Longeveron Inc (NASDAQ: LGVN)
LGVN Technical Analysis
2
| As on 25th Jan 2022 LGVN Share Price closed @ 7.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.44 & Buy for SHORT-TERM with Stoploss of 6.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LGVN Share Price
| Open | 6.48 | Change | Price | % |
| High | 8.06 | 1 Day | 0.37 | 5.52 |
| Low | 6.48 | 1 Week | -1.74 | -19.75 |
| Close | 7.07 | 1 Month | -12.36 | -63.61 |
| Volume | 1220683 | 1 Year | -0.34 | -4.59 |
| 52 Week High 42.30 | 52 Week Low 2.92 | ||||
NASDAQ USA Most Active Stocks
| XELA | 0.55 | 34.15% |
| AAPL | 159.78 | -1.14% |
| AMD | 111.13 | -4.63% |
| SOFI | 12.76 | -4.06% |
| NVDA | 223.24 | -4.48% |
| MSFT | 288.49 | -2.66% |
| SNDL | 0.48 | 4.35% |
| BBIG | 3.01 | 2.73% |
| INTC | 51.00 | -1.81% |
| PIXY | 1.55 | -9.88% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LGVN Daily Charts |
LGVN Intraday Charts |
Whats New @ Bazaartrend |
LGVN Free Analysis |
|
|
LGVN Important Levels Intraday
| RESISTANCE | 10.11 |
| RESISTANCE | 9.14 |
| RESISTANCE | 8.53 |
| RESISTANCE | 7.93 |
| SUPPORT | 6.21 |
| SUPPORT | 5.61 |
| SUPPORT | 5.00 |
| SUPPORT | 4.03 |
LGVN Target for Month January
| 4th UP TARGET | 14.49 |
| 3rd UP TARGET | 12.11 |
| 2nd UP TARGET | 10.64 |
| 1st UP TARGET | 9.17 |
| 1st DOWN TARGET | 4.97 |
| 2nd DOWN TARGET | 3.5 |
| 3rd DOWN TARGET | 2.03 |
| 4th DOWN TARGET | -0.35 |
LGVN Weekly Target
| 4th UP TARGET | 11.19 |
| 3rd UP TARGET | 9.87 |
| 2nd UP TARGET | 9.05 |
| 1st UP TARGET | 8.24 |
| 1st DOWN TARGET | 5.90 |
| 2nd DOWN TARGET | 5.09 |
| 3rd DOWN TARGET | 4.27 |
| 4th DOWN TARGET | 2.95 |
LGVN Target for Year 2022
| 4th UP TARGET | 88.31 |
| 3rd UP TARGET | 62.26 |
| 2nd UP TARGET | 46.15 |
| 1st UP TARGET | 30.05 |
| 1st DOWN TARGET | -15.91 |
| 2nd DOWN TARGET | -32.01 |
| 3rd DOWN TARGET | -48.12 |
| 4th DOWN TARGET | -74.17 |
Longeveron Inc ( NASDAQ USA Symbol : LGVN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LGVN Business Profile
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida. Address: 1951 NW 7th Avenue, Miami, FL, United States, 33136
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service